Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone

Lynn R Webster1 Scientific Affairs, PRA Health Sciences, Salt Lake City, UT, USA

Robert J Israel2 Clinical and Medical Affairs, Salix Pharmaceuticals, Bridgewater, NJ, USA, [email protected]Correspondence[email protected]

Pages 2509-2516 | Published online: 23 Oct 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

TavaniABianchiGFerrettiPManaraLMorphine is most effective on gastrointestinal propulsion in rats by intraperitoneal route: evidence for local actionLife Sci19802723221122177207014
PubMed Web of Science ®Google Scholar
KaufmanPNKrevskyBMalmudLSRole of opiate receptors in the regulation of colonic transitGastroenterology1988946135113562834257
PubMed Web of Science ®Google Scholar
CamilleriMDrossmanDABeckerGWebsterLRDaviesANMaweGMEmerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipationNeurogastroenterol Motil201426101386139525164154
PubMed Web of Science ®Google Scholar
PergolizziJVJrRaffaRBPappagalloMPeripherally acting µ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapyPatient Prefer Adherence20171110711928176913
PubMed Web of Science ®Google Scholar
HolzerPOpioid receptors in the gastrointestinal tractRegul Pept20091551–3111719345246
PubMed Web of Science ®Google Scholar
GalliganJJAkbaraliHIMolecular physiology of enteric opioid receptorsAm J Gastroenterol Suppl201421172125207608
PubMedGoogle Scholar
BellTJPanchalSJMiaskowskiCBolgeSCMilanovaTWilliamsonRThe prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1)Pain Med2009101354218721170
PubMed Web of Science ®Google Scholar
CookSFLanzaLZhouXGastrointestinal side effects in chronic opioid users: results from a population-based surveyAliment Pharmacol Ther200827121224123218363893
PubMed Web of Science ®Google Scholar
TutejaAKBiskupiakJStoddardGJLipmanAGOpioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer painNeurogastroenterol Motil201022442443020100280
PubMed Web of Science ®Google Scholar
CoyneKSLoCasaleRJDattoCJSextonCCYeomansKTackJOpioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart reviewClinicoecon Outcomes Res2014626928124904217
PubMedGoogle Scholar
PappagalloMIncidence, prevalence, and management of opioid bowel dysfunctionAm J Surg2001182Suppl 5AS11S18
Web of Science ®Google Scholar
Relistor [package insert]Bridgewater, NJSalix Pharmaceuticals2017
Google Scholar
ThomasJKarverSCooneyGAMethylnaltrexone for opioid-induced constipation in advanced illnessN Engl J Med2008358222332234318509120
PubMed Web of Science ®Google Scholar
SlatkinNThomasJLipmanAGMethylnaltrexone for treatment of opioid-induced constipation in advanced illness patientsJ Support Oncol200971394619278178
PubMedGoogle Scholar
ChamberlainBHCrossKWinstonJLMethylnaltrexone treatment of opioid-induced constipation in patients with advanced illnessJ Pain Symptom Manage200938568369019713070
PubMed Web of Science ®Google Scholar
MichnaEBlonskyERSchulmanSSubcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled studyJ Pain201112555456221429809
PubMed Web of Science ®Google Scholar
RauckRSlatkinNEStamblerNHarperJRIsraelRJRandomized, double-blind trial of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic noncancer painPain Pract201717682082827860208
PubMed Web of Science ®Google Scholar
Amitiza [package insert]Deerfield, ILTakeda Pharmaceuticals America2016
Google Scholar
Movantik [package insert]Wilmington, DEAstraZeneca Pharmaceuticals2017
Google Scholar
LeppertWWoronJThe role of naloxegol in the management of opioid-induced bowel dysfunctionTherap Adv Gastroenterol201695736746
PubMed Web of Science ®Google Scholar
YuanCSWeiGFossJFO’ConnorMKarrisonTOsinskiJEffects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trialJ Pharmacol Exp Ther2002300111812311752106
PubMed Web of Science ®Google Scholar
IyerSSRandazzoBPTzanisELEffect of subcutaneous methyl-naltrexone on patient-reported constipation symptomsValue Health201114117718321211500
PubMed Web of Science ®Google Scholar
LewisSJHeatonKWStool form scale as a useful guide to intestinal transit timeScand J Gastroenterol19973299209249299672
PubMed Web of Science ®Google Scholar
YuanCSFossJFO’ConnorMMethylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trialJAMA2000283336737210647800
PubMed Web of Science ®Google Scholar
CuppolettiJChakrabartiJTewariKMalinowskaDHMethadone but not morphine inhibits lubiprostone-stimulated Cl-currents in T84 intestinal cells and recombinant human ClC-2, but not CFTR Cl-currentsCell Biochem Biophys2013661536322918821
PubMed Web of Science ®Google Scholar
WongBSCamilleriMLubiprostone for the treatment of opioid-induced bowel dysfunctionExpert Opin Pharmacother201112698399021385112
PubMed Web of Science ®Google Scholar
WebsterLRBrennerDMBarrettACPatersonCBorteyEForbesWPAnalysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer painJ Pain Res2015877178026586963
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadone

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date